These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 3526272)

  • 1. [Pathogenetic substantiation of the use of immunomodulating preparations in the treatment of chronic viral hepatitis B in children].
    Nisevich NI; Cherednichenko TV; Uchaĭkin VF
    Pediatriia; 1986 May; (5):23-7. PubMed ID: 3526272
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of chronic hepatitis B].
    Carreño V; Montaño L; Torres M
    Rev Clin Esp; 1983 Oct; 171(1):73-6. PubMed ID: 6197728
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunotherapy of chronic active hepatitis (HBsAg+) with calf thymus extract (TFX-Polfa). Clinical evaluation].
    Cianciara J; Babiuch L; Górska E; Kassur B
    Pol Tyg Lek; 1984 Aug; 39(33):1097-101. PubMed ID: 6390376
    [No Abstract]   [Full Text] [Related]  

  • 4. [Indicators of cellular immunity in various types of treatment of children with chronic hepatitis B].
    Idrisova RS; Tsoĭ IG
    Pediatriia; 1984 Aug; (8):16-8. PubMed ID: 6333670
    [No Abstract]   [Full Text] [Related]  

  • 5. [Mechanisms of chronic hepatitis in viral hepatitis B. Hypotheses as rational principles in immune modulating and virostatic therapy of chronic hepatitis B].
    Markus R; Baumgaŕten R; Fengler JD
    Z Arztl Fortbild (Jena); 1988; 82(8):363-8. PubMed ID: 3043935
    [No Abstract]   [Full Text] [Related]  

  • 6. [Favorable outcome in chronic active hepatitis caused by B virus in childhood].
    Cadrobbi P; Bortolotti F; Crivellaro C; Rugge M; Armigliato M; Realdi G; Bertaggia A
    Minerva Pediatr; 1984 Jul; 36(13-14):685-9. PubMed ID: 6503897
    [No Abstract]   [Full Text] [Related]  

  • 7. [Interferon treatment in chronic hepatitis B].
    Pastore G; Santantonio T; Milella M; Iacovazzi T; Longo A; Pietromatera G
    Minerva Gastroenterol Dietol; 1995 Mar; 41(1):97-102. PubMed ID: 7619970
    [No Abstract]   [Full Text] [Related]  

  • 8. Current concepts in the diagnosis and management of hepatitis B surface antigen-positive chronic active hepatitis.
    Davis GL; Czaja AJ
    J Clin Gastroenterol; 1981 Dec; 3(4):381-8. PubMed ID: 6175681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards a rational therapy for hepatitis B.
    Ganem D
    J Clin Invest; 1998 Sep; 102(5):867-8. PubMed ID: 9727053
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use of reaferon and antioxidants in children with chronic hepatitis].
    Frolov VM; Peresadin NA; Sidorova VS; Germanov VT; Pustovoĭ IuG
    Pediatriia; 1992; (4-6):60-2. PubMed ID: 1408577
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of chronic hepatitis B and C with alpha interferon].
    Hess G
    Z Gastroenterol Verh; 1991 Mar; 26():149-51. PubMed ID: 1714130
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pathogenesis and alpha-2 interferon treatment of chronic hepatitis B].
    Pirotte J
    Rev Med Liege; 1996 Aug; 51(8):514-21. PubMed ID: 8927872
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of chronic hepatitis B with human lymphoblastoid interferon: results of a controlled trial.
    Mazzella G; Villanova N; Abdu-Ahmed M; Barbara L; Saracco G; Rizzetto M; Cancellieri C; Roda E
    Chemioterapia; 1988 Dec; 7 Suppl 3():12-4. PubMed ID: 3073868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Interferon treatment of chronic viral hepatitis].
    Pirovino M
    Ther Umsch; 1992 May; 49(5):302-9. PubMed ID: 1377840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levamisole and interferon in children with chronic hepatitis B.
    Ruiz-Moreno M; García R; Rua MJ; Serrano B; Moraleda G; Feijoo E; Bartolomé J; Ortiz F; Castillo I; Carreño V
    Hepatology; 1993 Aug; 18(2):264-9. PubMed ID: 7687978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Preliminary evaluation of the results of treatment of chronic active hepatitis (HBsAg+) with calf thymus extract (TFX-Polfa)].
    Juszczyk J
    Pol Tyg Lek; 1984 Aug; 39(33):1085-9. PubMed ID: 6504737
    [No Abstract]   [Full Text] [Related]  

  • 17. [Management of chronic hepatitis B].
    Telegdy L
    Orv Hetil; 1997 Jun; 138(22 Suppl 1):1462-5. PubMed ID: 9221375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Viral hepatitis in children].
    Uchaĭkin VF
    Pediatriia; 1989; (7):7-13. PubMed ID: 2780165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [HBs-antigen-positive chronic aggressive hepatitis].
    Müller R; Schmidt FW
    Fortschr Med; 1984 Apr; 102(16):449-54. PubMed ID: 6202611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current and future uses of biological response modifiers in the treatment of viral hepatitis.
    Van Thiel DH
    J Okla State Med Assoc; 1994 Jul; 87(7):319-22. PubMed ID: 8089777
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.